Admetsys' FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital
Posted:
Admetsys Corporation, a biomedical technology company specializing in critical care automation, announced today that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
S-PRO has become a member of SwissICT, the largest professional association for the Information and Communications Technology industry in Switzerland. Read the full article here.
Registration for 2024 MedConnect North event is now open and places have been filling up - reserve your place today & don't miss out!
Date: 26 September
Time: 9am - 4.30pm
Register here.
Attendees
Sponsors and
Exhibitors
Agenda
Webinars
Contact us